ABSTRACT: Twenty barrows were designated as fast-growing ( F G) and their littermates designated as slow-growing ( S G) based on birth, weaning, and 56-d weight. Half of each group received 70 pg of porcine somatotropin (pST)/kg BW daily beginning at 40 kg BW. At 60 and 105 kg BW, blood was collected every .5 h for 12 h beginning 1 h before pST injection, fat biopsies were taken for in vitro lipogenic activity, and insulin erythrocytes were isolated for receptor binding. Swine treated with pST had elevated ADG (.95 vs .88 kgid; P < . l ) and reduced days t o slaughter (61 vs 67; P < .1). The pST-treated pigs had less average backfat (2.73 vs 3.96 cm; P < .Or), larger longissimus muscle areas (32.3 vs 28.2 cm2; P < .05), and a higher percentage of muscle (56.3 vs 50.3%; P < . O l ) than control pigs. Exogenous pST increased protein (17.4 vs 13.2%; P < .05) and decreased fat (22.9 vs 37.1%; P < .05). The FG pigs had higher ADG (.98 vs .86 kg/d; P < .01) and required fewer days to slaughter (57 vs 71; P < .Ol) than SG pigs.
Introduction
Consumers associate pork with high-fat, unhealthy products. Tope1 (1 986) stated that although great strides have been taken to reduce fat, the average pork carcass contains 30 to 35% fat. Breidenstein and Carpenter (1983) emphasized that for the meat and livestock industry to remain competitive they must find ways to reduce fat. Evidence suggests that exogenous somatotropin in swine with different growth potentials from the same genetic background.
Therefore, the objectives of this study were to determine the effects of somatotropin on growth and carcass traits, hormonal and metabolic profiles, lipogenic activity of adipose tissue, and insulin binding to erythrocyte receptors from fast-and slow-growing swine with similar genetic potentials.
Materials and Methods
Forty barrows from 10 litters of a similar genetic population were selected and used in a 2 x 2 factorial arrangement with pST administration and rate of growth as main effects. Twenty barrows were placed in the fast-growing (FG) group; their 20 littermates were placed in the slow-growing ( SG) group based on weights at birth, weaning (28 d), and 56 d of age. Birth weights varied by < 5% between pairs of littermates selected, whereas both weaning and 56-d weights were 2 25% greater for each barrow in the FG group than for its littermate SG barrow.
One-half of each group was randomly selected to receive 70 pg of pST (pST-LGCOMP-1448/9, PitmanMoore, Terre Haute, IN)/kg BW daily beginning at an average treatment group weight of 40 kg BW ( k 7 kg; 10 wk of age) and continuing until slaughter at 108 kg BW. The other half received daily placebo injections of sterile bicarbonate buffer vehicle, pH 9.4. The pST and placebo solutions were prepared weekly and stored at -20°C until they were used. Subcutaneous injections over the trapezius muscle area of the neck were administered at approximately 0700 daily. Dosages were adjusted weekly according to individual weight gains.
All animals were randomly assigned to individual one-half slatted floor pens in a conventional barn. A diet consisting of 20% CP and 1.15% lysine was available ad libitum until an average treatment group weight of 60 kg BW was reached, at which time the protein level was reduced to 18% CP and the lysine content reduced t o .95% (NRC, 1988) .
Animal and Carcass Data Collection
Growth and carcass data were collected on six animals per treatment group (n = 24). Animal weights and feed consumption were measured weekly and ADG, feed efficiency ratios, and days to slaughter were calculated. All animals were evaluated for structural soundness and mobility at mean treatment group weights of 40, 60, and 108 kg BW.
Animals were slaughtered at 108 kg BW and carcasses chilled overnight (18 h ) at 2°C. The left side of each carcass was weighed, physically dissected into three components (lean and fat, bone, and skin), and weighed again, and percentage composition was calculated. Soft tissue, lean and fat, was ground twice using a ground beef plate and random samples were taken for chemical analysis (AOAC, 1980) . The opposite side of each carcass was fabricated into retail cuts trimmed to 1.27 cm of fat after standard carcass evaluation measurements had been taken. Dressing percentage and percentage of lean cuts, primal cuts, and muscle were calculated.
Taste panel evaluations were performed with a trained panel (Cross et al., 1978 ) using a 9-point scale; 1 was the most undesirable and 9 was the most desirable. Rib chops, 2.54 cm thick, were cooked at 218°C for 8 min on one side and 9 min on the other side to an internal temperature of 71°C. Samples were evaluated for flavor, juiciness, tenderness, and overall satisfaction. Duplicate 13-mm cores were removed and used for Warner-Bratzler shear force determinations.
Blood Sample Collection and Analysis
At mean treatment group weights of 60 kg ( + 5 kg; 17 wk) and 105 kg ( + 9 kg; 27 wk) BW, four animals per treatment group ( n = 16) were fitted with indwelling vena cava catheters, under local anesthesia 12 to 18 h before blood sample collection. All animals were allowed free access t o feed and water while remaining in their individual pens. Samples for hormonal and metabolic profiles were collected every .5 h for 12 h beginning 1 h before pST injection at 0700. At 60 kg BW, serum samples were analyzed for growth hormone (pST), insulin ( INS), and IGF-I. At 105 kg BW, in addition to serum measurements, plasma was also collected for determination of plasma glucose (GLU), blood urea nitrogen (BUN), and serum nonesterified fatty acids ( NEFA) .
Serum pST concentrations were determined by a double-antibody RIA procedure (Althen and Gerrits, 1976) . The first antibody was baboon anti-porcine growth hormone (Hoffman-LaRoche, Nutley, N J). The second antibody used was goat anti-monkey (Rhesus) gamma globulin ( P 3 Lot 6TA21, Antibodies, Davis, CAI. The purified porcine pST (ppST-IF, USDA) was donated by D. G. Bolt to be used as the radioiodinated hormone and for use as standards. The pST was iodinated according t o the procedures of Greenwood et al. (1963) and separated on a Sephadex G-75 column. The average recovery of 2.5 and 5.0 ng of pST added to 100 pL of serum and corrected for endogenous pST was 110.0% (Schneller, 1987) . Increasing amounts of serum (50, 100, 150, 200 , and 250 pL) produced a curve parallel to the standard curve. Also, crossreactivity with porcine prolactin was determined t o be < -001%. The assay sensitivity was .77 ngimL with an intraassay CV of 8.30% and an interassay CV of 12.23%.
Serum INS levels were determined by the procedures of Hale and Randle (1963) . Assay sensitivity was .063 ng/mL with intra-and interassay CV of 9.65 and 19.20%, respectively. Serum samples were also analyzed for IGF-I levels following procedures of Scott et al. (1987) . In addition, BUN and GLU were analyzed using a Baker Model 600 automatic centrifical analyzer (Baker Instruments Corporation, Allentown, PA) . Serum NEFA concentrations were determined by a modification of the enzymatic colorimetric method by the Wako Industries (Osaka, Japan) NEFA (NEFA-C) test kit (Beerman et al., 1987) .
Five-milliliter blood samples for insulin receptor assays were collected into tubes containing 3 mL of CPD solution (dihydrate trisodium citrate, 2.63 g; monohydrate citric acid, .33 g; monohydrate monosodium phosphate, .22 g; and glucose anhydrous, 2.32 g per 100 mL of sterile water) and stored overnight before assaying. Erythrocyte receptor preparation and binding activity was determined using methods outlined by Gambhir et al. (19781, Eng et al. (19801, and Rizkalla et al. (19781, as modified by Ector (1987) . Samples were centrifuged at 400 x g for 10 min and the plasma discarded. Erythrocytes were washed twice with .9% NaCl (saline) to remove the CPD and centrifuged for 10 min at 400 x g at 20°C and the supernatant was aspirated. The erythrocyte pellet was resuspended in an equal volume of saline and layered on top of 3 mL of chilled Ficoll-hypaque gradient medium (Histopaque-1077, Sigma Chemical Co.) and centrifuged at 400 x g for 20 min. The supernatant was aspirated and erythrocytes resuspended in saline and the previous step repeated. Two parts buffer G (pH = 8.0; HEPES, 11.915 g; Tris, 6.057 g; MgC12, 2.033 g; EDTA, .744 g; dextrose, 1.802 g; CaC12, 1.470 g; NaC1, 2.922 g; KC1, .373 g; bovine serum albumin, 1.0 g per 1 L of sterile water) was added and centrifuged at 400 x g at 4°C for 10 min and the buffer aspirated. Next, 6.5 mL of buffer G was added and 300 pL of the cell suspension was placed in a culture tube containing 100 pL of buffer G, 25 pL of [12511insulin, and 75 pL of insulin standard with various concentrations of 0, .5, 1, 2, 4, 8, 10, 100, and 1,000 ng/mL of insulin. Tubes were vortexed, incubated overnight ( 12 h ) at 4"C, and vortexed again and 200 pL was transferred into chilled microfuge tubes containing 200 pL of dibutylphthalate and buffer G. After vortexing and centrifuging at 400 x g for 2.5 min at 4"C, the supernatant was aspirated and the tube tip removed with a hot scalpel and placed in a culture tube for determination of bound 1251. Incubating increasing concentrations of erythrocytes (.28 to 6.66
x lo9 erythrocytes/mL of cell suspension) with .1 ng of
[1251]insulin resulted in a linear increase in specific insulin binding ranging from 1 to 32%. Nonspecific binding (binding in the presence of 1.0 pg/mL of insulin) remained at < 4.0% of total counts as [12511insulin was added at concentrations ranging from 44.6 to 714.8 pM per tube. Specificity of receptor binding was examined by incubating erythrocytes with increasing concentrations of insulin, glucagon, or somatotropin ( . 5 to 1,000 ngimL). Although binding of [1251]insulin was completely inhibited by 10 ng/mL of ET AL.
insulin, glucagon and somatotropin did not inhibit binding ( P > .05), even at concentrations of 1.0 pgi mL. Receptor characteristics (concentrations and affinities) are reported in the Results and Discussion section.
Subcutaneous adipose tissue biopsies were also obtained from each animal at 60 and 105 kg BW using a spring-loaded biopsy gun following the procedure outlined by Steele et al. (1974) and Mersmann et al. ( 198 1) . Samples were transported to the laboratory in a physiological saline solution held at 37°C and sliced to approximately 100 mg within 1 h after removal using a prewarmed ( 3 7 "C) , specially designed microtome (Ector, 1987) . Lipogenic activity of the adipose tissue slices was determined according to procedures described by Steele et al. (1974) and Mersmann et al.
( 198 11, using the following modifications outlined by Ector (1987) . Tissue biopsies (approximately 100 mg) were placed in siliconized 25-mL Erlenmeyer flasks containing 3 mL HEPES-Hanks buffer (Hanks balanced salt solution with 5.56 mM glucose, 25 mM HEPES, 3% bovine serum albumen, and 1.0 pCi U-14C-glucose). A polyethylene well containing Whatman #1 filter paper was suspended in each flask and flasks were sealed under an atmosphere of 95% 0 2 5 % C02 with rubber stoppers. Samples were incubated in an oscillating water bath at 37°C for 2 h and then .1 mL of 25% KOH was added to the filter paper and .3 mL of 1 N Has04 added to the buffer. Samples were incubated for one additional hour, the filter paper was removed, and the samples were stored in scintillation vials containing 5 mL of scintillation fluid (Bio-HP) overnight before counting. Lipid slices were blotted dry and stored overnight in test tubes containing 10 mL of ch1oroform:methanol (2 : 1). The upper layer was removed and the lower layer was totally evaporated. Five milliliters of scintillation fluid was added to vials and stored overnight before counting. Data are reported as micromoles of glucose incorporated-gram of tissue-l.2 hours-l.
Statistical Analysis
Main effect variables, pST treatment and growth rate, and appropriate interactions were analyzed in a 2 x 2 factorial arrangement in a split-plot design over sample period, as determined by BW (60 and 105 kg), using the GLM procedure of SAS (1988) . Hormonal and metabolic data were analyzed with respect to individual time response and 12-h average response. When significant effects were found, means were separated by LSD procedures (Steel and Torrie, 1980) .
Results and Discussion
Administration of pST increased growth rates of both FG and SG swine (Figure 1) . The pST-treated swine required fewer ( P e . 1 ) days to slaughter ( 6 1 Figure 1 . Effects of administration of porcine somatotropin (pST) on the growth rate of fast-and slowgrowing swine. FG-pST = fast-growing, somatotropin treated pigs; FG-NpST = fast-growing, untreated pigs; SGpST = slow-growing, somatotropin-treated pigs; SGNpST = slow-growing, untreated pigs. 67) while consuming less ( P < .Ol) feed (202.5 vs 247.5 kg) than control pigs (Table 1) . Campbell et al. (1990a) , Goodband et al. (1990) , Smith and Kasson (19911, and Dunshea et al. (1992) all reported increased growth rates and decreased feed consumption in pST-treated swine. The FG pigs had higher ADG (.98 vs .86 kgid; P < .Ol), required fewer days on feed (57 vs 71; P < . O l ) , and consumed less feed (212.2 vs 238.3 kgianimal; P < .01) than SG swine. This is in agreement with the research of Krider et al. (19461, Baird et al. (1952) , and, more recently, Campbell et al. (1990a) .
Exogenous pST also increased ( P < . l ) ADG by up to 12.0% in both FG and SG swine (1.03 and .87 vs .92 and .84 kgid) compared with control FG and SG swine and improved ( P < .O 1) feed efficiency by 14 to 22% in both groups (3.59 and 3.52 vs 4.18 and 4.49 kg of feed/ kg of gain) over control swine. Similar results have been reported previously by Boyd et al. (19861, Campbell et al. (19881, and Smith and Kasson (199 l ) , who all reported 10 to 24% increases in ADG and 19 to 35% improvements in feed conversion.
In a recent review of the literature, administration of pST was not found to be detrimental to the health of growing swine (Busby and Stender, 1991) . In the present study, pST had no effect ( P > .05) on the structural soundness or mobility of swine. This agrees with the results of Chung et al. (1985) and McLaren et al. (19901, who found no adverse effects of pST on the soundness or health of growing swine.
No pST x growth rate interactions occurred ( P > .05) for carcass or sensory attributes, indicating that pST affected both FG and SG swine to the same extent (Tables 1 and 2) .
Regardless of growth rate, swine treated with pST had pronounced improvements in carcass attributes.
The pST-treated swine had larger ( P < .01) longissimus muscle areas (32.3 vs 28.2 cm2), longer ( P < .05) carcass lengths (82 vs 79.5 cm), and improved ( P < .01) USDA grades (.75 vs 2.95) compared with control swine (Table 1) . Increases in length and longissimus muscle area of pST-treated animals were first noted by Lee and Schaffer (1933) in rats and in swine by Turman and Andrews (19551, Goodband et al. (1990) , and Hagen et al. (1991) .
Administration of exogenous pST also decreased ( P < . O l ) average backfat (2.72 vs 3.96 cm) and 10th rib fat (1.82 vs 3.20 cm) in pST-treated vs control swine. A reduction in fat was also noted by Boyd et al. (19861, Etherton et al. (1986) , McLaughlin et al. (19891, and McNamara et al. (1991) .
The pST-treated swine had higher ( P < .01) percentage of lean cuts (58.9 vs 54.1%), muscle (56.3 vs 50.3%), and primal cuts (70.7 vs 67.2%) and a reduced ( P < .Ol) dressing percentage (67.1 vs 69.3) compared with control swine (Table 2) . These results indicate a more favorable 1ean:fat ratio in pST-treated animals. Similar findings have been noted recently by Boyd et al. (1988) and Campbell et al. (1989) .
Furthermore, it was determined that pST improved body composition. The pST administration decreased ( P < .05) carcass fat by > 38% (22.8 vs 37.0%) and increased ( P < .05) protein by 32% (17.4 vs 13.2%), moisture by 22% (58.2 vs 43.6%), bone by 16% (15.4 vs 13.3%), and skin by 31% (9.4 vs 7.2%) in pST compared with control pigs (Table 2 ). This is in agreement with the findings of Campbell et al. (19891, Beermann et al. (19901, and McNamara et al. ( 199 1) , who reported that pST decreased body fat while increasing protein and moisture content.
In addition, pST had no detrimental effects ( P > .01) on color (3.0 vs 2.9), marbling (2.2 vs 2.2), or firmness (3.0 vs 3.4) scores compared with scores of meat from control swine ( Table 2 ) . There were no negative ( P > .05) effects on organoleptic traits in products from pST vs control swine such as flavor (7.4 vs 7.51, juiciness (7.3 vs 7.6), and overall satisfaction (7.2 vs 7.5). This is in agreement with the results of Chung et al. (1985) and Beermann et al. (19901, who found no detrimental effects on marbling, color, firmness, juiciness, or flavor.
Although there was a slight decrease ( P < .05) in the tenderness ratings by panelists (7.1 vs 7.6) of products derived from pST-treated animals compared with control animals, both products were well within acceptable ranges and the differences were not significant for Warner-Bratzler shear force determination (3.95 vs 3.70 kg). These results are in agreement with those of Prusa et al. (1989 Prusa et al. ( , 1990 and Beermann et al. (19901, who also found slight differences in tenderness in muscle from pST-treated animals but concluded that they were of no practical importance t o the industry. There were no differences ( P > .05) between FG and SG swine for any carcass or organoleptic traits. No interactions between pST treatment and growth rate were significant except for serum pST levels, indicating that pST administration had similar effects on INS and other metabolites in animals with different rates of growth ( Table 3 ) . Elevation of pST due to pST administration was greater ( P < .05) in FG swine than in SG swine (46.0 vs 19.3 ngimL) at 105 kg BW but the plasma pST concentration was similar ( P > . 0 5 ) between FG and SG control pigs ( 1.9 vs 1.8 ng/mL) ( Table 3 ) . This conflicts with the reports of Baird et al. (1952) , Wangsness et al. (1977) , and Arbona et al. (1988) , who found that lines of pigs selected for rapid lean gain had increased circulating levels of pST over pigs selected for slow growth. This is possibly due to the method of animal selection. Campbell et al. (1990a) found that pigs selected for slower growth had higher plasma pST levels than pigs selected for faster growth.
Furthermore, pigs treated with pST had higher ( P < .01) levels of serum pST at 105 kg BW than at 60 kg BW (32.7 vs 14.0 ng/mL), whereas control pigs were not different ( P > .05) at either weight period (1.9 vs ***P < .001.
1.8 ng/mL) ( Table 3 ). In contrast, Klindt and Stone (1984) found that pST levels declined as weight increased from 60 to 100 kg BW. However, this constant level in control pigs agrees with earlier findings of Baker et al. (19561, Althen and Gerrits (1976) , and Trenkle (1977) that circulating pST levels remain constant as the animal's weight increases with age, and there is a dilution of the concentration of pST per unit of tissue. This dilution effect causes a decreased growth rate (Baker et al., 1956; Siers and Hazel, 1970) ; however, others have also demonstrated that administration of exogenous pST increases circulating levels of pST by up to 10-fold (Chung et al., 1985; Sillence and Etherton, 1987; Campbell et al., 1990a) and that elevated levels of pST continue to improve both growth performance and carcass traits (Chung et al., 1985; Bidanel et al., 1991) . Serum pST concentrations peaked at approximately 1 h after pST injections to levels 10-to 20-fold over basal values (Figure 2 ). This elevation agrees with previous results that pST levels are elevated greater than 10-fold from 1 to 3 h after injection of pST (Sillence and Etherton, 1987) . In addition, pST concentrations remained elevated in comparison with those in control animals throughout 24 h; however, by 12 h after pST injection, serum pST concentrations approached the concentrations found in treated pigs at 1 h before pST injection.
Exogenous pST administration also increased ( P < .01) levels of IGF-I (492.0 vs 159.0 ng/mL) over control animals (Table 3 ). This has been well documented previously by Wray-Cahen et al. ( 199 1) . However, pST did not increase IGF-I levels similarly at both sample periods. Swine treated with pST had higher ( P < .01) IGF-I levels at 105 kg than at 60 kg BW (640.5 vs 347.0 ng/mL), which might indicate that growth hormone utilization is higher at 60 kg BW, whereas concentrations in control pigs were not significantly different (125.6 vs 192.9 ngimL). Serum IGF-I concentrations averaged over both sample periods and growth rates in pST-treated swine were elevated threefold in comparison with those in control swine over the entire day (Figure 2 ).
The pST treatment also elevated ( P < .01) serum INS levels in both FG and SG swine (3.9 and 3.2 ngi mL, respectively) compared with control FG and SG pigs (.8 and 1.0 ng/mL, respectively) ( Table 3) . This is in agreement with the reports of Etherton and Kensinger (19841, Gopinath and Etherton (19881, Wray-Cahen et al. (1991) , and Dunshea et al. (1992) , who also found increases in INS concentrations when pST was administered. Insulin levels increased, reaching a peak after approximately 10 h, and were elevated above control levels before pST injections (Figure 2 ).
Swine treated with pST had higher blood GLU (98.3 vs 76.6 mg/dL, P < .Ol) values than did control animals (Table 3) . A n increase in GLU with pST administration has been reported previously (Turman and Andrews, 1955; Gopinath and Etherton 1988; Wray-Cahen et al., 1991) . The GLU concentrations in pST swine differed from those in control swine by approximately 3 to 4 h after pST injection and were again comparable by 24 h after pST injection.
The BUN values were lower ( P < .O 1) in pSTtreated (10.2 vs 19.1 mg/dL) than in control swine (Table 3 and remained consistently lower throughout the sampling period. This has been previously documented in cattle (Eisemann et al., 1989) and in swine by Dunshea et al. (1992) and Wray-Cahen et al. (1991) , who also noted reductions in BUN levels in animals treated with somatotropin. The pST treatment increased lipolysis, as indicated by increased ( P < . l ) NEFA levels (Table 3) Administration of exogenous pST decreased the incorporation of glucose into C02 and lipid in adipose tissue from pST swine (.345 and 1.85 vs .575 and 2.71 pmol*g1.2 h-l, P < .01) compared with that in control swine ( Table 4 ) . This agrees with earlier research by and Magri et al. (19901, who reported up to a 64% decrease in lipid synthesis in swine treated with 70 pg of pST-kg BW-I.dT1 for 7 d.
At 60 kg BW, the adipose tissue from FG swine had a lower lipogenic activity than adipose tissue from SG swine (.299 and 1.83 vs .921 and 3.61 pmol*g1-2 h-l, P < .01 for C 0 2 and lipid incorporation, respectively, The binding characteristics of insulin to erythrocyte receptors have been studied previously and shown that the binding of insulin to erythrocyte receptors reflects the activity of insulin on target tissue (Gambhir et al., 1978; Dons et al., 1981; Ector, 1987) . Therefore, due to the plentiful supply of erythrocytes, they are commonly used to estimate the interaction of insulin target tissue receptors. The administration of pST increased ( P < .05) the percentage of specific binding of insulin to erythrocyte receptors (7.04 and 7.45% vs 6.07 and 6.60%) in both FG and SG swine vs control swine ( 
1992).
This conflict in data may be due to the fact that various tissues have different responsiveness to pST.
A growth rate x pST interaction did occur ( P c .05) for both receptor affinity and concentration. However, this seemed to be of little biological importance. Thus, it would seem, based on the results of this study, that the antagonism of pST to insulin occurs through some mechanism that affects the tissue at the post-receptor stage.
In conclusion, these results suggest the possibility that pigs with different rates of growth from the same genetic background, and treated with pST, have different rates of somatotropin clearance and(or) utilization. In addition, exogenous pST tends to render the tissue insensitive or less sensitive to insulin.
Although insulin levels are increased due to pST treatment, there is also an elevation in blood glucose levels. This insensitivity t o insulin is not due to decreased specific binding to receptor sites by insulin. Furthermore, pST seems to have a direct effect of increasing lipolysis due to the episodic increase in serum growth hormone levels followed by a similar sporadic increase in NEFA concentrations later during the day.
It seems that the effects of pST on nitrogen retention and protein deposition may be caused by IGF-I. This is due to a constant increase in serum IGF-I caused by the elevated pST concentration, which was followed by a similar constant reduction in BUN, indicating an increase in protein deposition. Therefore, by whatever method pST has its effects, it seems that the exogenous administration of pST does have a positive effect on serum pST, IGF-I, and INS levels in littermate swine with fast or slow growth rates.
These results also indicate that pST administration decreases the lipogenic activity in adipose tissue from both FG and SG pigs. This reduction in lipogenic activity corresponds similarly to the 38% reduction of body fat in pST-treated swine. This further agrees with previous research that pST antagonizes INS, thereby reducing lipid synthesis in swine. However, the fact that INS binding to erythrocyte receptors is increased by pST treatment suggests that the insensitivity of the tissue is not due to an alteration in receptor-INS binding activity but may be located past the receptor interaction stage. Therefore, we conclude that further investigations are needed in this area to determine at what point and how the tissue becomes insensitive to insulin.
Implications
Somatotropin administration improves growth rate of both fast-and slow-growing swine with the same genetic background. However, somatotropin-treated, slow-growing pigs never reached the rate of growth performance obtained by untreated, fast-growing animals, indicating a limitation for different animals with the same genetic background. Therefore, it is essential that sound selection practices be maintained to ensure maximum benefit. Limitations other than growth hormone affect growth rates of swine of the same genetic background, thus indicating that environmental factors cannot be ignored when one uses somatotropin to improve growth performance. However, if appropriate environmental manipulations (protein requirements, etc.) are used, administration of somatotropin would improve growth and carcass characteristics of both fast-and slow-growing swine.
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